The Osteoarticular Manifestations in Patients With Gitelman Syndrome

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorSecond Affiliated Hospital, School of Medicine, Zhejiang University

About this trial

Patients with clinically and genetically confirmed Gitelman Syndrome are screened for CPPD, and the clinical and radiographic manifestations are collected and analyzed.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients confirmed with Gitelman Syndrome

Disqualifiers

Patients with other confounding situations such as Bartter Syndrome, hyperparathyroidism

Trial population

Patients clinically and genetically confirmed with Gitelman Syndrome

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • conventional radiograph or computed tomography

    Diagnostic test

    patients with gitelman syndrome evaluated with conventional radiograph or computed tomography

Treatment groups

120 Participants
are divided into 1 treatment group
Group A: Patients with Gitelman Syndrome1 intervention

Trial outcomes

Primary outcomes

1

The presence of chondrocalcinosis

The presence of chondrocalcinosis on conventional radiograph or computed tomography in patients with Gitelman Syndrome

Time frame
From the enrollment to the performance of the CPPD screen

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.